Cargando…
Long-term omalizumab use in the treatment of exercise-induced anaphylaxis
Reported is a case of a 39-year-old male who was diagnosed with exercise-induced anaphylaxis (EIA). He was initially treated prophylactically with fexofenadine, montelukast, and ranitidine. He also used an epinephrine autoinjector as needed. He was refractory to these medications and continued to ha...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
OceanSide Publications, Inc.
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662542/ https://www.ncbi.nlm.nih.gov/pubmed/29070274 http://dx.doi.org/10.2500/ar.2017.8.0204 |